Dr. Clemens Scherzer, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• International Medical And Technological University School Of Medicine (vignan)

  Medical School, 1995

• English

• German

• Motor Impulsivity in Parkinson Disease: Associations with COMT and DRD2 polymorphisms, 2014-04-21

• The NINDS Parkinson's Disease Biomarkers Program, 2015-10-07

• Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease, 2023-04-03

• GBAandAPOEImpact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study, 2022-02-02

• MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration, 2014-04-16

• Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping, 2022-10-03

• Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's Liu et al, 2016-11-18

• Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients, 2016-08-03

• Association of DualLRRK2G2019S andGBAVariations With Parkinson Disease Progression Association of DualLRRK2G2019S andGBAVariations With Parkinson Disease Progression, 2021-04-21

• Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease, 2020-02-12

• Specific splice variants are associated with Parkinson's disease, 2013-09-20

• Genomewide Association Study of Parkinson's Disease Clinical Biomarkers in 12 Longitudinal Patients' Cohorts, 2019-09-10

• PGC-1a, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease, 2010-10-06

• Network Analysis IdentifiesSOD2mRNA as a Potential Biomarker for Parkinson's Disease, 2014-10-03

• Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment, 2023-03-02

• Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis, 2012-08-17

• Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture, 2021-02-15

• Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice, 2017-02-14

• A Feed-Forward Circuit of EndogenousPGC-1aandEstrogen Related Receptor aRegulates the Neuronal Electron Transport Chain, 2016-03-03

• Plasma-borne indicators of inflammasome activity in Parkinson's disease patients, 2021-01-04

• Metallothioneins as Dynamic Markers for Brain Disease in Lysosomal Disorders, 2014-10-24

• Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of TauIn Vivo, 2010-07-15

• Meta-analysis of Parkinson disease: Identification of a novel locus,RIT2, 2011-12-02

• Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease, 2021-05-06

• ß2-Adrenoreceptor is a Regulator of the a-Synuclein Gene Driving Risk of Parkinson's Disease, 2017-09-01

• Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource Iwaki et al, 2021-05-07

• Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease, 2022-06-21

• Differences in the Presentation and Progression of Parkinson's Disease by Sex, 2020-10-01

• Glucosylceramide in cerebrospinal fluid of patients withGBA-associated and idiopathic Parkinson's disease enrolled in PPMI, 2021-11-22

• Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric disease, 2023-09-18

• Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study, 2021-07-07

• Chipping away at diagnostics for neurodegenerative diseases, 2009-03-10

• Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts, 2017-06-16

• Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples AUTOPHAGY, 2020-10-28

• Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous a-synuclein in human neurons, 2022-09-16

• Association ofSNCAwith Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study, 2011-09-23

• Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease, 2010-05-09

• Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites, 2021-03-10

• Finding Useful Biomarkers for Parkinson's Disease, 2018-08-15

• Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study, 2020-07-10

• Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease, 2018-09-17

• Parkinson's disease-linkedLRRK2is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures, 2011-05-07